Farmak expands its range of drugs for treatment of acute (stroke) and chronic cerebrovascular disorders – Lira (citicoline). The Company's experts have developed and launched Lira as 30 ml syrup.
Farmak is actively working towards the treatment of cardiovascular and cerebrovascular diseases. In particular, it focuses on ensuring full-scale provision of proper quality and affordable treatment of acute and chronic cerebral circulation disorders in adults, and neurological diseases in children. To that end, the Company's experts have developed and launched the medicinal product Lira as 30 ml syrup.
The medicinal product is prescribed to adult patients in the acuity period and on the following states:
Lira Syrup can also be used to treat muscle hypertonia of the lower extremities in children, encephalopathy, infantile cerebral paralysis (ICP), traumatic brain injury, effects of neuroinfections, and ischemic conditions during prenatal development.
The course of treatment is at least 45 days.
The employees of the Company raised UAH 10,000 for children with Down syndrome, sent 250 kg of food and useful things for the inmates of the Surius Shelter, donated almost 5 liters of blood, visited a sorting station and delivered 8 tons of leaves to the compost pit. The Company’s Marathon of Kindness lasted three weeks […]
The Executive Director of Farmak became a finalist in TOP 25 Best Managers rating compiled by TOP 100. Ratings of the Largest. Volodymyr Kostiuk was recognized as an effective manager in the Leaders of Change category. The award ceremony took place as part of the Business Wisdom Summit. Volodymyr Kostiuk has been the Executive Director […]
On November 19, 2020, JSC Farmak hosted the VIII Scientific and Practical Conference of the School of Young Scientists, which was attended by almost 60 guests and employees of the Company. A total of 28 reports by Ukrainian scientists, specialists of the Company, as well as post-graduates and students of the Ukrainian leading universities were […]